HealthEquity Future Growth
Future criteria checks 4/6
HealthEquity is forecast to grow earnings and revenue by 32.1% and 11.4% per annum respectively. EPS is expected to grow by 30.3% per annum. Return on equity is forecast to be 12.1% in 3 years.
Key information
32.1%
Earnings growth rate
30.3%
EPS growth rate
Healthcare earnings growth | 27.9% |
Revenue growth rate | 11.4% |
Future return on equity | 12.1% |
Analyst coverage | Good |
Last updated | 15 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
1/31/2027 | 1,467 | 228 | 459 | 488 | 8 |
1/31/2026 | 1,315 | 158 | 405 | 423 | 13 |
1/31/2025 | 1,183 | 110 | 308 | 320 | 13 |
7/31/2024 | 1,099 | 106 | -198 | 308 | N/A |
4/30/2024 | 1,043 | 80 | -30 | 277 | N/A |
1/31/2024 | 1,000 | 56 | 197 | 243 | N/A |
10/31/2023 | 971 | 29 | 176 | 221 | N/A |
7/31/2023 | 938 | 13 | 169 | 212 | N/A |
4/30/2023 | 901 | -8 | 121 | 175 | N/A |
1/31/2023 | 862 | -26 | 32 | 151 | N/A |
10/31/2022 | 831 | -59 | 21 | 146 | N/A |
7/31/2022 | 795 | -62 | -71 | 120 | N/A |
4/30/2022 | 778 | -55 | -76 | 117 | N/A |
1/31/2022 | 757 | -44 | 4 | 141 | N/A |
10/31/2021 | 741 | -6 | 10 | 151 | N/A |
7/31/2021 | 741 | 1 | 99 | 181 | N/A |
4/30/2021 | 728 | 4 | 108 | 198 | N/A |
1/31/2021 | 734 | 9 | 85 | 182 | N/A |
10/31/2020 | 747 | 3 | 64 | 152 | N/A |
7/31/2020 | 724 | -20 | 34 | 117 | N/A |
4/30/2020 | 635 | 0 | 35 | 95 | N/A |
1/31/2020 | 532 | 40 | 63 | 105 | N/A |
10/31/2019 | 407 | 53 | 72 | 107 | N/A |
7/31/2019 | 320 | 90 | 96 | 118 | N/A |
4/30/2019 | 304 | 93 | 96 | 116 | N/A |
1/31/2019 | 287 | 74 | 98 | 113 | N/A |
10/31/2018 | 272 | 67 | 82 | 101 | N/A |
7/31/2018 | 258 | 61 | 67 | 95 | N/A |
4/30/2018 | 244 | 56 | N/A | 89 | N/A |
1/31/2018 | 230 | 47 | N/A | 82 | N/A |
10/31/2017 | 216 | 46 | N/A | 76 | N/A |
7/31/2017 | 202 | 41 | N/A | 70 | N/A |
4/30/2017 | 190 | 32 | N/A | 59 | N/A |
1/31/2017 | 178 | 26 | N/A | 46 | N/A |
10/31/2016 | 167 | 25 | N/A | 39 | N/A |
7/31/2016 | 155 | 24 | N/A | 35 | N/A |
4/30/2016 | 141 | 20 | N/A | 27 | N/A |
1/31/2016 | 127 | 17 | N/A | 27 | N/A |
10/31/2015 | 116 | 15 | N/A | 23 | N/A |
7/31/2015 | 107 | 14 | N/A | 17 | N/A |
4/30/2015 | 97 | 13 | N/A | 15 | N/A |
1/31/2015 | 88 | 12 | N/A | 15 | N/A |
10/31/2014 | 80 | 1 | N/A | 16 | N/A |
7/31/2014 | 74 | -1 | N/A | 16 | N/A |
4/30/2014 | 68 | -4 | N/A | 16 | N/A |
1/31/2014 | 62 | -7 | N/A | 18 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 2HE's forecast earnings growth (32.1% per year) is above the savings rate (1%).
Earnings vs Market: 2HE's earnings (32.1% per year) are forecast to grow faster than the German market (20.8% per year).
High Growth Earnings: 2HE's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 2HE's revenue (11.4% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: 2HE's revenue (11.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 2HE's Return on Equity is forecast to be low in 3 years time (12.1%).